Health Canada on Wednesday gave the nod to allow Pfizer-BioNTech's COVID-19 vaccine to be kept between -25 C and -15 C instead of ultra-cold conditions.

Pfizer and German partner BioNTech SE said they have begun delivering doses of their coronavirus vaccine candidates for human testing in the U.S. Trials in Germany had already begun.